Application of Bethesda System For Cervical Cytology at a Tertiary Care Centre


Preeti S. Bajaj
Priyanka Baviskar
Devangana M. Rajyaguru
Rajendra A. Chaudhari


For early screening of the cervical lesion cervical smear is a sensitive test and most widely used system for describing Pap smear result is The Bethesda System. Aims and Objectives : The present study was conducted to look for the epithelial cell abnormalities in cervix using Bethesda system of reporting for cervical cytology, to implicate The Bethesda System of reporting (2014) during assessment of Pap smear, to detect cervical cancer and its pre-cancerous lesions (LSIL-Low grade intraepithelial lesion and HSIL-High grade intraepithelial lesion) at an early stage by Pap smear examination and to create awareness about cervical cancer and importance of Pap smear as  a screening test in disease prevention. Materials and Methods: The present study was undertaken at a tertiary health care, out of 250 cervical smears, we excluded 10 smears which were inadequate to opine. So, the total of 240 smears got reported according to The Bethesda System 2014. Observations and Results:  The youngest patient was 18 year old and the oldest was 75 year old female. A total of 4% Pap smears were reported as unsatisfactory. The most common complaint of patients was discharge per vaginum which accounts for a total of 38% followed by abdominal pain is showed in 8% of cases. The most common infection was bacterial vaginosis followed by candida, Trichomonas. The frequency of normal (NILM) cases was 78%.ASCUS was found in 4.58%, LSIL was found in 9.17%, HSIL was found in 1.67% & SCC was found in 3.33% cases. Proportion of LSIL was more in age group 41-50 years i.e. 21.15 %. Conclusion : Pap test has significant utility worldwide. Bethesda system used for cervical cytology is not only a uniform & standard method but also gives descriptive diagnosis that helps clinicians in individualized patient management. It helps in preventing invasive cervical cancer by detecting & treating women with precancerous lesions & the effectiveness is determined by reduction in incidence & mortality.


How to Cite
Bajaj, P. S., Baviskar, P., Rajyaguru, D. M. ., & Chaudhari, R. A. . (2022). Application of Bethesda System For Cervical Cytology at a Tertiary Care Centre. MVP Journal of Medical Sciences, 171–178.


  1. Sherwani RK, Khan T, Akhtar K, Zeba A, Siddiqui FA, Rahman K, Afsan N. Conventional Pap smear and liquid based cytology for cervical cancer screening-A comparative study. Journal of Cytology. 2007; 24(4):167-172 DOI:
  2. Solomon D, Davey D, Kurman R et al. The 2001 Bethesda System Terminology for Reporting Results of Cervical Cytology. JAMA. 2002; 287(16):2114–2119 DOI:
  3. Denny L, Kuhn L, Pollack A, Wainwright H, Wright Jr TC. Evaluation of alternative methods of cervical cancer screening for resource-poor settings. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2000; 89(4):826-833 DOI:<826::AID-CNCR15>3.0.CO;2-5
  4. Torre LA, Islami F, Siegel RL, Ward EM, Jemal A. Global Cancer in Women. Burden and Trends. 2017; 26(4):444-457. DOI:
  5. Lopez MS, Baker ES, Maza M et al. Cervical cancer prevention and treatment in Latin America. Journal of Surgical Oncology. 2017; 115(5):615-618. DOI:
  6. Cutts FT, Franceschi S, Goldie S, Castellsague XD, De Sanjose S, Garnett G, Edmunds WJ, Claeys P, Goldenthal KL, Harper DM, Markowitz L. Human papillomavirus and HPV vaccines: A review. Bulletin of the World Health Organization. 2007; 85:719-726. DOI:
  7. Sachan PL, Singh M, Patel ML, Sachan R. A study on cervical cancer screening using pap smear test and clinical correlation. Asia Pac J Oncol Nurs. 2018; 5:337-341. DOI:
  8. Fonn S, Bloch B, Mabina M, Carpenter S, Cronje H, Maise C, Bennun M, Du Toit G, De Jonge E, Manana I, Lindeque G. Prevalence of pre-cancerous lesions and cervical cancer in South Africa-a multicentre study. South African Medical Journal. 2002; 92(2):148-156.
  9. Castle PE, Sideri M, Jeronimo J, Solomon D, Schiffman M. Risk assessment to guide the prevention of cervical cancer [serial online]. Am J Obstet Gynecol. 2007; 197:356.e1-356.e6. DOI:
  10. Nayar R, Wilbur D. The pap test and bethesda 2014. Acta Cytologica. 2015; 59:121-132 DOI:
  11. Murillo R, Herrero R, Sierra MS, Forman D. Cervical cancer in Central and South America: Burden of disease and status of disease control. Cancer Epidemiology. 2016; 44:S121-3M. DOI:
  12. Bal MS, Goyal R, Suri AK, Mohi MK. Detection of abnormal cervical cytology in Papanicolaou smears. Journal of Cytology/Indian Academy of Cytologists. 2012 Jan; 29(1):45. DOI:
  13. Nayar R, Wilbur DC, editors. The Bethesda system for reporting cervical cytology: Definitions, criteria, and explanatory notes. Springer. 2015 Apr 13. DOI:
  14. Roghaei MA, Afshar MN, Pooladkhan SH, Roghaie SH. Adequacy criteria and cytomorphological changes in liquiprep TM versus conventional cervical cytology. 2010.
  15. Verma I, JaIn V, Kaur T. Application of bethesda system for cervical cytology in unhealthy cervix. Journal of Clinical and Diagnostic Research: JCDR. 2014 Sep; 8(9):OC26. DOI:
  16. Sankaranarayanan R, Basu P, Wesley RS, Mahe C, Keita N, Mbalawa CC, Sharma R, Dolo Aaltaf, Shastri SS, Nacoulma M, Nayama M. Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa. International Journal of Cancer. 2004 Jul 20; 110(6):907-913. DOI:
  17. Vaghela BK, Vaghela VK, Santwani PM. Analysis of abnormal cervical cytology in papanicolaou smears at tertiary care center–A retrospective study. IJBAR. 2014; 5:47-49. DOI:
  18. Sreedevi A, Javed R, Dinesh A. Epidemiology of cervical cancer with special focus on India. International Journal of Women’s Health. 2015; 7:405. DOI:
  19. Altaf FJ, Mufti ST. Pattern of cervical smear abnormalities using the revised Bethesda system in a tertiary care hospital in Western Saudi Arabia. Saudi Med J. 2012 Jun 1; 33(6):634-639.
  20. Bukhari MH, Saba K, Qamar S, Majeed MM, Niazi S, Naeem S. Clinicopathological importance of Papanicolaou smears for the diagnosis of premalignant and malignant lesions of the cervix. Journal of Cytology/Indian Academy of Cytologists. 2012 Jan; 29(1):20. DOI: